Indivior (LON:INDV) Sets New 1-Year High at $1,734.00

Shares of Indivior PLC (LON:INDVGet Rating) hit a new 52-week high during trading on Tuesday . The stock traded as high as GBX 1,734 ($20.50) and last traded at GBX 1,728 ($20.43), with a volume of 12869 shares trading hands. The stock had previously closed at GBX 1,716 ($20.29).

Indivior Trading Up 0.5 %

The company has a 50 day moving average of GBX 1,097 and a 200 day moving average of GBX 583.87. The company has a current ratio of 1.70, a quick ratio of 1.52 and a debt-to-equity ratio of 121.59. The firm has a market cap of £2.36 billion and a price-to-earnings ratio of 8,209.52.

Indivior Company Profile

(Get Rating)

Indivior PLC, together with its subsidiaries, engages in the development, manufacture, and sale of buprenorphine-based prescription drugs for the treatment of opioid dependence and co-occurring disorders. The company's product pipeline focuses on treating opioid use disorder, addiction, and schizophrenia.

Further Reading

Receive News & Ratings for Indivior Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Indivior and related companies with MarketBeat.com's FREE daily email newsletter.